Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Norelgestromin is an active metabolite of the progestin norgestimate (Item No. 16547).1 Norelgestromin is formed from norgestimate via deacetylation in human liver microsomes. It is an agonist of the progesterone receptor and estrogen receptor α (ERα; EC50s = 11.1 and 43.4 nM, respectively) and an antagonist of the glucocorticoid and mineralocorticoid receptors (IC50s = 255 nM and 83.7 nM, respectively).2 Norelgestromin selectively binds to progestin receptors (IC50 = 4.61 nM for rabbit uterine receptors) over androgen receptors (IC50 = 222 nM for rat prostatic receptors) in radioligand binding assays.3 However, norelgestromin (1 nM) activates the androgen receptor in a transactivation assay in MDA-MB-231 breast cancer cells expressing the human receptor.4 Formulations containing norelgestromin in combination with ethynyl estradiol have been used as contraceptives and in the treatment of acne vulgaris in women.
WARNING This product is not for human or veterinary use.
1. Metabolism of norgestimate by human gastrointestinal mucosa and liver microsomes in vitro. J. Steroid Biochem. Mol. Biol. 38(4), 497-503 (1991).
2. Molecular action of norgestimate: New developments. Gynecol. Endocrinol. 31(6), 487-490 (2015).
3. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins. Contraception 41(4), 399-410 (1990).
4. Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-